The Big Data Steering Group set up jointly by the European Medicines Agency (EMA) and the Heads of Medicines Agencies Organisation (HMA) published its work plan for 2022-2025 on 28 July.
The aim is to improve the integration of data analysis in health regulators’ assessments of medical products or clinical trials.
The work plan was developed based on the recommendations of the EMA-HMA joint working group published in 2020 as a conclusion to the work carried out by the joint working group...